Early Discontinuation of Antibiotics in Paediatric High-risk Febrile Neutropenia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Hematologic Malignancies
Related studies linked through entity extraction aliases.
The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE2
Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies
- Status
- TEMPORARILY_NOT_AVAILABLE
- Phase
- N/A
A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies
- Status
- SUSPENDED
- Phase
- NA
A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy
- Status
- RECRUITING
- Phase
- PHASE3
Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
- Status
- RECRUITING
- Phase
- PHASE1
Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention
- Status
- RECRUITING
- Phase
- PHASE2
Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China
- Status
- COMPLETED
- Phase
- N/A
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.
- Status
- RECRUITING
- Phase
- PHASE1
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
- Status
- RECRUITING
- Phase
- PHASE2